Signature Equity Partners’s AtriCure ATRC Stock Holding History

Signature Equity Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.81K	Buy	+315	New	+$8.86K	﹤0.01%	846

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Signature Equity Partners's ATRC Position: Q2 2026 in Review

Signature Equity Partners opened a new position in AtriCure (ATRC) in Q2 2026: 315 shares worth $8.81K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Signature Equity Partners held 315 shares of AtriCure worth $8.81K as of Q2 2026.
AtriCure was a new Signature Equity Partners position in Q2 2026.
AtriCure made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #846 holding.
252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.